These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3494 related articles for article (PubMed ID: 11208485)

  • 1. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
    Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
    Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bradykinin as a major endogenous regulator of endothelial function.
    Gryglewski RJ; Uracz W; Chłopicki S; Marcinkiewicz E
    Pediatr Pathol Mol Med; 2002; 21(3):279-90. PubMed ID: 12056503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of angiotensin-converting enzyme inhibitor induced thrombolysis in Wistar rats.
    Gryglewski RJ; Swies J; Uracz W; Chłopicki S; Marcinkiewicz E
    Thromb Res; 2003 Jun; 110(5-6):323-9. PubMed ID: 14592556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy.
    Busse R; Fleming I; Hecker M
    J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S31-6. PubMed ID: 7508049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture.
    Bishop-Bailey D; Larkin SW; Warner TD; Chen G; Mitchell JA
    Br J Pharmacol; 1997 May; 121(1):125-33. PubMed ID: 9146896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of endothelium-derived bradykinin in the control of vascular tone.
    Hecker M; Dambacher T; Busse R
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S55-61. PubMed ID: 1282631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level.
    Hecker M; Pörsti I; Bara AT; Busse R
    Br J Pharmacol; 1994 Jan; 111(1):238-44. PubMed ID: 8012702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2.
    Henrion D; Dechaux E; Dowell FJ; Maclour J; Samuel JL; Lévy BI; Michel JB
    Br J Pharmacol; 1997 May; 121(1):83-90. PubMed ID: 9146891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of cytosolic calcium, prostacyclin and nitric oxide by bradykinin and the ACE inhibitor ramiprilat in porcine brain capillary endothelial cells.
    Wiemer G; Popp R; Schölkens BA; Gögelein H
    Brain Res; 1994 Feb; 638(1-2):261-6. PubMed ID: 7515323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thienopyridines: effects on cultured endothelial cells.
    Ziemianin B; Olszanecki R; Uracz W; Marcinkiewicz E; Gryglewski RJ
    J Physiol Pharmacol; 1999 Dec; 50(4):597-604. PubMed ID: 10639010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo endothelial interaction between ACE and COX inhibitors.
    Gryglewski RJ; Chlopicki S; Swies J
    Prostaglandins Leukot Essent Fatty Acids; 2005 Feb; 72(2):129-31. PubMed ID: 15626595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostacyclin and nitric oxide contribute to the vasodilator action of acetylcholine and bradykinin in the intact rabbit coronary bed.
    Lamontagne D; König A; Bassenge E; Busse R
    J Cardiovasc Pharmacol; 1992 Oct; 20(4):652-7. PubMed ID: 1280723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts.
    Linz W; Wiemer G; Schölkens BA
    J Mol Cell Cardiol; 1992 Aug; 24(8):909-19. PubMed ID: 1331474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 1beta induces functional prostaglandin E synthase in cultured human umbilical vein endothelial cells.
    Uracz W; Uracz D; Olszanecki R; Gryglewski RJ
    J Physiol Pharmacol; 2002 Dec; 53(4 Pt 1):643-54. PubMed ID: 12512699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids.
    Swierkosz TA; Mitchell JA; Warner TD; Botting RM; Vane JR
    Br J Pharmacol; 1995 Apr; 114(7):1335-42. PubMed ID: 7541688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1beta, transforming growth factor-beta1, and bradykinin attenuate cyclic AMP production by human pulmonary artery smooth muscle cells in response to prostacyclin analogues and prostaglandin E2 by cyclooxygenase-2 induction and downregulation of adenylyl cyclase isoforms 1, 2, and 4.
    El-Haroun H; Bradbury D; Clayton A; Knox AJ
    Circ Res; 2004 Feb; 94(3):353-61. PubMed ID: 14670842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enalapril and quinapril improve endothelial vasodilator function and aortic eNOS gene expression in L-NAME-treated rats.
    De Gennaro Colonna V; Rossoni G; Rigamonti A; Bonomo S; Manfredi B; Berti F; Muller E
    Eur J Pharmacol; 2002 Aug; 450(1):61-6. PubMed ID: 12176110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of endothelial pleiotropic actions of angiotensin converting enzyme inhibitors and statins.
    Gryglewski RJ; Uracz W; Swies J; Chlopicki S; Marcinkiewicz E; Lomnicka M; Madej J
    Ann N Y Acad Sci; 2001 Dec; 947():229-45; discussion 245-6. PubMed ID: 11795271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of bradykinin in the rat isolated perfused heart: role of kinin receptors and endothelium-derived relaxing factor.
    Baydoun AR; Woodward B
    Br J Pharmacol; 1991 Jul; 103(3):1829-33. PubMed ID: 1657268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 175.